Shares of Sihuan Pharmaceutical Holdings Group Ltd 0460.HK, China largest cardio-cerebal vascular drugmaker, were indicated to open 31.5 percent higher ahead of their Hong Kong trading debut on Thursday, following a $741 million IPO.
The pre-open market price for Sihuan Pharmaceutical, which markets its products through a network covering about 10,000 hospitals and medical institutions across China, was at HK$6.05 per share, compared with an IPO price of HK$4.60.
No comments:
Post a Comment